Judith Wolf
Infectious Disease · Philadelphia, PANPI 1972554624
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,229,513 of the $1,229,543 with a category attached, or 100.0%. Merck accounts for 89.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $308,900 and has fallen 83.2% since, to $51,975 in 2024. Among infectious disease clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $5144.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.1M
- Modernatx, Inc.$92K
- Seqirus USA Inc$38K
- Astellas Pharma US Inc$30
What the payments were for
- Consulting fees$1,229,513100%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 221 | $1,099,638 |
| Modernatx, Inc. | 12 | $91,900 |
| Seqirus USA Inc | 5 | $37,975 |
| Astellas Pharma US Inc | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moderna Covid-19 Vaccine$91,875
How this compares
$1,229,543 in reported general payments places this provider in the 95th percentile of 457 infectious disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $41,253 |
| Atazanavir Sulfate | 12 | $6,009 |
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 11 | $4,607 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Philadelphia
- David HornPhiladelphia$2.1M
- Karam MounzerPhiladelphia$712K
- William ShortPhiladelphia$520K
- Pablo TebasPhiladelphia$160K
- Lisa SpacekPhiladelphia$131K
- Ian FrankPhiladelphia$112K
- Jay KostmanPhiladelphia$77K
- Ramon GadeaPhiladelphia$55K
- Vincent LorePhiladelphia$52K
- Katharine BarPhiladelphia$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.